NLM Logo

TI-23 human monoclonal antibody MeSH Supplementary Concept Data 2024


MeSH Supplementary
TI-23 human monoclonal antibody
Unique ID
C089553
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C089553
Entry Term(s)
MCA C23-HSA-glycine
TI-23
lyophilized regavirumab-human serum albumin-amino acetic acid
Registry Number
0
Heading Mapped to
Glycine / *analogs & derivatives
*Serum Albumin
*Antibodies, Monoclonal, Humanized
Frequency
3
Note
a passive immunotherapeutic agent for cytomegalovirus (CMV) infection; developed by Teijin Ltd.
Source
Arzneimittelforschung 1994 Jul;44(7):890-8
Date of Entry
1994/10/24
Revision Date
2019/10/31
TI-23 human monoclonal antibody Preferred
lyophilized regavirumab-human serum albumin-amino acetic acid Broader
page delivered in 0.005s